StatPearls Question of the Week – #5

In the recent clinical trials involving Chimeric Antigen Receptor T cell therapy (CAR-T), which complication led to a halt in the studies?

A. Myocardial infarction

B. Disseminated intravascular coagulation

C. Neurotoxicity

D. Systemic thrombosis